Meningioma clinical trials provide valuable information about how to diagnose, treat, prevent and ultimately cure these complex tumors. Most of these studies are designed to compare two or more treatments: the best option currently available and a novel therapy that has the potential to produce better survival outcomes and quality of life, or cause fewer side effects. Other trials are designed to learn more about how or why the condition develops, determine how to reduce the likelihood of recurrence or study new options for screening and prevention.
Some of the most recent clinical trials for meningioma have evaluated:
- What role chemotherapy can play in meningioma treatment and which chemo medications are most effective
- How tumor markers can help predict which patients will respond most favorably to specific treatments
- Whether carbon ion-based treatments can be more effective than traditional postoperative radiation
- Various options for addressing chronic, meningioma-induced neurological defects and cognitive impairment
At Moffitt Cancer Center, our clinical trials program has contributed to many key developments in brain cancer research. In fact, today’s most effective meningioma treatments were once only available through clinical trials – and a number of those trials took place at Moffitt. Through our clinical research program, patients have unique opportunities to access the latest therapies before those options are available in other settings, and opportunities continue to open up as our researchers steadily work toward finding a brain cancer cure.
For more information about our meningioma clinical trials, call 1-813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form online. No referral is necessary to make an appointment.